Clinical Pharmacology Considerations for Peptide Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 14, 2023
December 13, 2023
1609c8ed-4d50-4235-8a00-9c63176affe8
Related Documents
Psychedelic Drugs: Considerations for Clinical Investigations
Guidance DocumentJune 23, 2023Center for Drug Evaluation and Research
Quality Considerations for Topical Ophthalmic Drug Products
Guidance DocumentDecember 27, 2023Center for Drug Evaluation and Research
General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products
Guidance DocumentSeptember 7, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.